Esofagite Eosinofílica

Referências:

 

1. Liacouras CA, Furuta GT, Hirano I et al. Eosinophilic esophagitis: Updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128(1): 3–20.

2. Kelly KJ, Lazenby AJ, Rowe PC et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: Improvement with an amino acidbased formula. Gastroenterology 1995; 109(5): 1503–1512.

3. Liacouras CA, Ruchelli E. Eosinophilic esophagitis. Curr Opin Pediatr 2004; 16(5): 560–566.

4. Mishra A, Hogan SP, Brandt EB et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001; 107(1): 83–90.

5. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003; 112(4): 796–797.

6. Spergel JM, Beausoleil JL, Mascarenhas M et al. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002; 109(2): 363–368.

7. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N Engl J Med 2004; 351(9): 940–941.

8. Straumann A, Simon HU. Eosinophilic esophagitis: Escalating epidemiology? J Allergy Clin Immunol 2005; 115(2): 418–419.

9. Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child 2006; 91(12): 1000–1004.

10. Veerappan GR, Perry JL, Duncan TJ et al. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: A prospective study. Clin Gastroenterol Hepatol 2009; 7(4): 420–426.

11. Liacouras CA, Spergel JM, Ruchelli E et al. Eosinophilic esophagitis: A 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005; 3(12): 1198–1206.

12. Furuta GT, Liacouras CA, Collins MH et al. Eosinophilic esophagitis in children and adults: A systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133(4): 1342–1363.

13. Gonsalves N, Policarpio-Nicolas M, Zhang Q et al. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc 2006; 64(3): 313–319.

14. Pasha SF, DiBaise JK, Kim HJ et al. Patient characteristics, clinical, endoscopic, and histologic findings in adult eosinophilic esophagitis: A case series and systematic review of the medical literature. Dis Esophagus 2007; 20(4): 311–319.

15. Muller S, Pühl S, Vieth M et al. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy 2007; 39(4): 339–344.

16. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: A systematic review. Eur J Gastroenterol Hepatol 2006; 18(2): 211–217.

17. Aceves SS, Newbury RO, Dohil R et al. Esophageal remodeling in pediatric eosinophilic esophagitis. J Allergy Clin Immunol 2007;= 119(1): 206–212.

18. Aceves SS, Newbury RO, Chen D et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to
topical corticosteroids. Allergy 2010; 65(1): 109–116.

19. Mishra A, Wang M, Pemmaraju VR et al. Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology 2008; 134(1): 204–214.

20. Kagalwalla AF, Sentongo TA, Ritz S et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006; 4(9): 1097–1102.

21. Markowitz JE, Liacouras CA. Eosinophilic esophagitis. Gastroenterol Clin North Am 2003; 32(3): 949–966.

22. Liacouras CA, Wenner WJ, Brown K et al. Primary eosinophilic esophagitis in children: Successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 1998; 26(4): 380–385.

23. Schaefer ET, Fitzgerald JF, Molleston JP et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: A randomized trial in children. Clin Gastroenterol Hepatol 2008; 6(2): 165–173.

24. Faubion WA Jr, Perrault J, Burgart LJ et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998; 27(1): 90–93.

25. Teitelbaum JE, Fox VL, Twarog FJ et al. Eosinophilic esophagitis in children: Immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002; 122(5): 1216–1225.

26. Noel RJ, Putnam PE, Collins MH et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis.
Clin Gastroenterol Hepatol 2004; 2(7): 568–575.

27. Aceves SS, Dohil R, Newbury RO et al. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2005; 116(3): 705–706.

28. Remedios M, Campbell C, Jones DM et al. Eosinophilic esophagitis in adults: Cinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 2006; 63(1): 3–12.

29. Aceves SS, Bastian JF, Newbury RO et al. Oral viscous budesonide: A potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 2007; 102(10): 2271–2279.

30. Konikoff MR, Noel RJ, Blanchard C et al. A randomized, double-blind, placebocontrolled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131(5): 1381–1391.

31. Dohil R, Newbury R, Fox L et al. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139(2): 418–429.

32. Helou EF, Simonson J, Arora AS. 3-yrfollow- up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am J Gastroenterol 2008; 103(9): 2194–2199. 33. Caldwell JM, Blanchard C, Collins MH et al. Glucocorticoid-regulated genes in eosinophilic esophagitis: A role for FKBP51. J Allergy Clin Immunol 2010; 125(4): 879–888.

34. Straumann A, Conus S, Degen L et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010; 139(5): 1526–1537, e1.

35. Straumann A, Conus S, Degen L et al. Budesonide as induction treatment for active eosinophilic esophagitis in adolescents and adults: A randomized, doubleblind, placebo-controlled study (Bee-I trial). Gastroenterology 2008; 134(Suppl): A104.

36. Neumann D, Alexander G, Farrugia G et al. A new therapy for eosinophilic esophagitis in adults: Efficacy of budesonide–rincinol gel for 6 weeks in patients with dysphagia. Am J Gastroenterol 2008; 103: 19.

37. Grotz VL, Munro IC. An overview of the safety of sucralose. Regul Toxicol Pharmacol 2009; 55(1): 1–5.

38. Krishna SG, Kakati BR, Olden KW, BrownDK. Treatment of eosinophilic esophagitis: Is oral viscous budesonide superior to swallowed fluticasone spray? Gastroenterol Hepatol (N.Y.). 2011; 7(1): 55–59.

39. MARTINDALE: The Complete Drug Reference. Micromedex 1.0 (Healthcare Series).